Arginine/Citrulline Synergistic Vasodilation:Optimized 2:1 Ratio Formula with Enhanced Stability (Clinical DataIncluded)"
Title:
"Arginine/Citrulline Synergistic Vasodilation:Optimized 2:1 Ratio Formula with Enhanced Stability (Clinical DataIncluded)"
Meta Description:
Blue Eyes Biotech reveals the ideal 2:1arginine-citrulline combination delivering 58% greater NO production. Discoverour patented stabilization technology for maximum efficacy.
Scientific Breakthrough in Nitric OxideEnhancement
Blue Eyes Biotech CO., Ltd. presents aclinically validated 2:1 arginine-citrulline complex that outperformssingle-ingredient formulations. Our research demonstrates:
• 58%increased nitric oxide production vs standalone ingredients
• Sustainedplasma arginine elevation for 8+ hours
• 40%reduction in oxidative degradation through advanced stabilization
Clinical Validation:
→Doppler-confirmed 32% greater blood flow (90-minute post-dose)
→ 2.5X fasterworkout recovery in athlete studies
→ Optimal 2:1ratio maximizes the urea cycle conversion
Technical Innovations:
✔ Dual-coating protection system preventsmoisture absorption
✔ pH-balanced formulation maintainspotency in liquid applications
✔ 100% soluble with zero aftertaste
"Our amino acid matrix creates acontinuous NO production cycle," explains Dr. Mark Richardson, ChiefSports Nutrition Scientist.
For Product Developers:
• Ready-to-useVasoDrive™ AC Complex
• Multipledelivery formats:
-Instant-mix powder sticks
-Effervescent tablets
-RTD shot formulations
• Completetechnical package:
-Pharmacokinetic studies
-18-month stability data
-GRAS certification documents
Request Clinical Study & SampleSpecifications:
